Bradyarrhythmia After Remdesivir Administration in SARS-CoV-2: A Review of Literature and Meta-Analysis of Observational Studies in Epidemiology

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has required timely and informed decisions about treatment recommendations for clinical practice. One such drug used for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is remdesivir (RDV), and sever...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Jammali, Safa, Al-Zakhari, Rana, Sheets, Nicholas, Mahtani, Arun, Stefanishina, Veronika, Isber, Nidal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239507/
https://www.ncbi.nlm.nih.gov/pubmed/35836734
http://dx.doi.org/10.14740/cr1377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239507/
https://www.ncbi.nlm.nih.gov/pubmed/35836734
http://dx.doi.org/10.14740/cr1377

Ejemplares similares